National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

From the 11/12/2021 release of VAERS data:

This is VAERS ID 1472196

Government Disclaimer on use of this data

Case Details

VAERS ID: 1472196 (history)  
Form: Version 2.0  
Sex: Female  
Location: Foreign  
Submitted: 0000-00-00
Entered: 2021-07-15
Vaccin­ation / Manu­facturer Lot / Dose Site / Route

Administered by: Other       Purchased by: ?
Symptoms: Abortion spontaneous
SMQs:, Termination of pregnancy and risk of abortion (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: FOLIC ACID
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Folic acid supplementation; Pregnancy (Patient no longer pregnant at the time of reporting.)
Diagnostic Lab Data:
CDC Split Type: GBPFIZER INC2021773019

Write-up: miscarriage/Early miscarriage; This is a spontaneous report from a contactable consumer received from the Regulatory Agency (RA). The regulatory authority report number is GB-MHRA-WEBCOVID-202106211354209200-TE0LJ, Safety Report Unique Identifier GB-MHRA-ADR 25511084. A 27-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: FA1027), via an unspecified route of administration on 12Jun2021 as dose 1, single for COVID-19 immunization. Medical history included pregnancy (patient no longer pregnant at the time of reporting) and folic acid supplementation, both from an unknown date and unknown if ongoing. Patient has not had symptoms associated with COVID-19 and not had a COVID-19 test. Patient is not enrolled in clinical trial. Patient is not currently breastfeeding. Concomitant medications included folic acid taken for vitamin supplementation, start and stop date were not reported. The patient experienced miscarriage/early miscarriage on an unspecified date. It was reported that the medicine had an adverse effect on any aspect of the pregnancy. It was also reported that the patient experienced miscarriage 24 hours after receiving first dose. Patient was exposed to the medicine first-trimester (1-12 weeks). The reporter assessed the event as non-serious. Patient has not tested positive for COVID-19 since having the vaccine. The outcome of the event was recovered on an unspecified date. No follow up attempts are possible. No further information is expected.

New Search

Link To This Search Result:

Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166